Medical Writing Authorship: Positioning

John Holstein — AI Solutions Strategist, Medical Writing — Indegene
Interview Round 1 — 2026-07-29
Read the Rubric Alignment addendum first

Zodiac Solutions' 2026-08-03 evaluation-rubric guidance scores "Hands-on in Medical Writing" at 2/5, the lowest of seven criteria, well below Life Science R&D Clinical/Regulatory Experience (5/5). The evidence below still holds and is worth having ready if pressed, but it is a short, confident answer to give if asked, not the primary story to lead the interview with. See Indegene_AISolutionsStrategist_R1_RubricAlignment_2026_08_03.html for the corrected emphasis order.

Mental Model — The Core Answer

The JD's "10–15+ years" requirement is written for a career medical writer, but the role it describes — by the posting's own "who we're looking for" language — is medical writing plus AI platform governance plus client advisory, not traditional hand-authorship. Measured against a literal writer's resume, John's background looks like a gap. Measured against what the role actually does, it is a direct match: 42 years of licensed clinical documentation practice under NRC and FDA oversight, hands-on ICH/CTD content structuring with Amgen's clinical writers for FDA NDA submissions, and a production agentic writing system at NewsRx that he built and governs end to end. This is not a defense of a gap. It is the stronger candidacy for the job as written.

Key Evidence Points

Licensed clinical documentation (1984–present, 42 yrs): Registered Pharmacist and Registered Nuclear Pharmacist — continuous, licensed medical documentation (patient records, drug therapy documentation, regulatory submissions) as a core function of the license, not an adjacent skill.
Amgen, Nov 2023–Apr 2024: Hands-on regulatory content work, not architecture from the outside — led the cross-functional team including CMC clinical writers, structuring ICH-standard CTD content (Module 3 CMC, expanded to Modules 4–5 Safety and Efficacy after a production milestone) generated by the GenAI system for FDA NDA submissions, under a GenAI-to-SCA feedback loop maintaining template and content consistency under GxP change control.
NewsRx, Nov 2025–present: A fully agentic writing system in production — the AI drafts, under John's governance, at scale, with a four-layer quality framework (automated hallucination detection plus blinded SME review) delivering 88% reviewer preference for AI-generated content over originals. This is exactly the "AI-enabled content workflow" experience the JD asks for over traditional hand-authorship.
Florida nuclear pharmacist licensure regulations: John co-authored the regulatory language itself — not just consumed or complied with it — that became the national model, drafted then held for public comment before finalization. Direct evidence of writing regulatory text that other licensed practitioners now operate under.
The JD's own stated preference: The posting's "who we're looking for" section explicitly favors AI-enabled content workflow experience over traditional hand-authorship — the exact profile John has, not the one a career medical writer without platform governance experience has.

Anticipate the Follow-Up

If pressed on specific document types — protocols, CSRs, investigator brochures — give the accurate boundary, not a bigger claim:

Accurate boundary of the claim John has governed and structured the systems and templates that produce this content, and has worked directly with the writers producing it (Amgen CMC/CTD team). He has not personally authored a CSR or an IB line-by-line. State this plainly if asked — it is the honest edge of the evidence, and the rest of the case does not need to overreach past it to be strong.

How Each Point Validates

EvidenceHow it checks out
RPh / RNPh licenseVerifiable state and NRC licensure record spanning 1984–present; continuous, not lapsed.
Amgen engagementNamed client engagement, defined dates, defined deliverable (CTD Modules 3–5) and named team structure (CMC clinical writers).
NewsRx systemLive production system with a measurable, stated outcome (88% reviewer preference) — not a pilot or a claim without a metric.
FL regulatory languagePublic record: drafted text, public comment period, finalized rule — independently checkable, not self-reported only.

Verbatim Interview Phrases

"The role you're describing isn't a traditional medical writing role either, by your own posting — it's medical writing plus AI platform governance plus client advisory. I bring 42 years of licensed clinical documentation practice under NRC and FDA oversight, hands-on ICH/CTD content structuring with Amgen's clinical writers for FDA NDA submissions, and a production agentic writing system at NewsRx that I built and govern end to end. That combination is a better match for what this role actually does than a career medical writer with no AI platform governance experience would be."
  • "I've been writing licensed clinical documentation since 1984 — that's not adjacent to medical writing, that's the same discipline under a different regulator."
  • "At Amgen I wasn't advising from outside the writing team — I was structuring the CTD content their CMC clinical writers were producing for an FDA NDA submission."
  • "At NewsRx the AI does the drafting, in production, at scale, and I govern the quality bar — 88% reviewer preference over the originals. That's the medical writing workflow of the next ten years, not the last ten."
  • "I've drafted regulatory language other licensed practitioners now operate under — that's authorship with consequence, not a credential on paper."
Indegene — AI Solutions Strategist, Medical Writing — Round 1 Primer — Confidential, prepared for John Holstein
← Back to index